Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study. (2025). SKIN The Journal of Cutaneous Medicine, 9(4), s582. https://doi.org/10.25251/gdd40x24